Clinical Trials Directory

Trials / Completed

CompletedNCT03715959

Nipple Aspirate Fluid in Detecting Breast Cancer

Phi29 Motor Nanopore for Single Molecule Sensing: Breast Nipple Aspirate Fluid

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Accepted

Summary

This trial studies nipple aspirate fluid in detecting breast cancer. Nipple aspirate fluid may better detect breast cancer earlier than current methods used for screening such as mammograms and breast examinations.

Detailed description

PRIMARY OBJECTIVES: I. To obtain nipple aspirate fluid (NAF) samples from non-lactating women subjects at least 40-years-old. II. To analyze the samples using a novel protein nanopore-based detection platform to evaluate the efficacy of the platform for breast cancer diagnosis through detection of biomarkers. OUTLINE: Participants and healthy volunteers undergo collection of nipple aspirate fluid from both breasts. After completion of study, participants are followed up at 1 year.

Conditions

Interventions

TypeNameDescription
PROCEDUREAspiration of BreastUndergo NAF
PROCEDUREBiospecimen CollectionUndergo NAF

Timeline

Start date
2020-12-10
Primary completion
2024-01-01
Completion
2024-01-01
First posted
2018-10-23
Last updated
2025-02-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03715959. Inclusion in this directory is not an endorsement.